Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2009, Article ID 543746, 11 pages
http://dx.doi.org/10.1155/2009/543746
Research Article

Peroxisome Proliferator-Activated Receptor Gamma Polymorphisms and Coronary Heart Disease

1Service d'Epidémiologie et de Santé Publique, Institut Pasteur de Lille, Lille; INSERM, U744, Lille; Université Nord de France, Lille; UDSL, 59019 Lille, France
2Kaiser Permanente Division of Research, Oakland, CA 94612, USA
3INSERM, U558, Toulouse, Department of Epidemiology, Paul Sabatier-Toulouse Purpan University, 31073 Toulouse, France
4The Department of Epidemiology and Public Health, Queen’s University Belfast, Belfast BT71NN, Northern Ireland, UK
5Department of Epidemiology and Public Health, EA 3430, University of Strasbourg, Faculty of Medicine, 67085 Strasbourg, France
6Stanford Prevention Research Center, Stanford University School of Medicine, Stanford, CA 94305-5705, USA
7INSERM, U780, 94807 Villejuif, Hôpital Kremlin-Bicêtre, France
8Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA 94305, USA
9Stanford Human Genome Center, Stanford, CA 94304, USA
10Falk Cardiovascular Research Center, Stanford Falk Cardiovascular Research Building, Stanford, CA 94305-5406, USA

Received 11 June 2009; Accepted 26 August 2009

Academic Editor: Mostafa Badr

Copyright © 2009 Jean Dallongeville et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

Supplementary Table 1: Baseline characteristics of controls according to PPARG genotypes in the PRIME Study

Supplementary Table 2: Baseline characteristics of white controls according to the PPARG C-689T genotype in the ADVANCE Study

Supplementary Table 3: Baseline characteristics of white controls according to the PPARG C-681G genotype in the ADVANCE Study

Supplementary Table 4: Baseline characteristics of white controls according to the PPARG Pro12Ala genotype in the ADVANCE Study

Supplementary Table 5: Baseline characteristics of white controls according to the PPARG C1431T genotype in the ADVANCE Study

  1. Supplementary Material